Virtual Medicinal Product (VMP)
-
Nalidixic acid 300mg/5ml oral suspension
Name Details
|
Current Name
Nalidixic acid 300mg/5ml oral suspension
|
Start Date
11-03-2003
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 5
- UDFS UOM
- ml
- Unit Dose UOM
- spoonful
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
J01MB02
| BNF |
|
Current BNF
05011200
|
Start Date
04-04-2022
|
End Date
|
|
Previous BNF
05011200
|
Start Date
22-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
|
Code
|
Start Date
|
End Date
|
| 41952511000001106 |
09-06-2023 |
|
| 324579006 |
11-03-2003 |
08-06-2023 |
VMP Ingredients
VMP ingredients table
| Nalidixic acid |
Based on Ingredient Substance |
|
60 mg |
1 ml |
Name
Nalidixic acid
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
60
Strength and UOM (Dmr)
1
Parent Products
-
VTM
Nalidixic acid
-
VMP
(Current) Nalidixic acid 300mg/5ml oral suspen...
Virtual Medicinal Product Pack (VMPP) Information